PD-L1, an immune checkpoint ligand expressed on macrophages, activated T-cells, B-cells, DCs, cancer cells, and some epithelial cells under inflammatory conditions, suppresses the immune system by binding the PD-1 molecule on T-cells. The gene discussed is CD274; the disease is cancer.